. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol. 1998 Jul;55(7):937-45. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(82)
833 ± 379
pg/mL
ELISA;
Other/Not Specified;
In-house
McKhann et al., 1984
Aβ42
(CSF)
CTRL-
CNC
(60)
1485 ± 473
pg/mL
ELISA;
Other/Not Specified;
In-house
tau-total
(CSF)
AD
(82)
663 ± 481
pg/mL
ELISA;
Other/Not Specified;
In-house
McKhann et al., 1984
tau-total
(CSF)
CTRL-
CNC
(60)
387 ± 167
pg/mL
ELISA;
Other/Not Specified;
In-house

Recommends

Please login to recommend the paper.

Comments

Comments on this Paper

No Available Comments

Make a Comment

To make a comment you must login or register.